Inactivating mutations in the solute carrier family 7 member 5 (SLC7A5) gene lead to a neurodevelopmental disorder characterized by microcephaly, seizures and neuropsychiatric manifestations (1). This evidence concerns the gene SLC7A5 and neurodevelopmental disorder.